Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antigens Involved in Adaptive Immunity

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Therapeutic vaccination for active induction of T cell immunity against cancer, ready for a rich harvest after 40 years.

Journal for immunotherapy of cancer·2026

Same author

Branched tetrameric lactoferricin peptides modified with diaminopropionic acid exhibit potent antimicrobial and wound-healing activities.

Frontiers in pharmacology·2025

Same author

Dysfunctional CD4 T cells in an oncovirus-specific TCR-transgenic in vivo model.

Nature communications·2025

Same author

Machine Learning-Identified Potent Antimicrobial Peptides Against Multidrug-Resistant Bacteria and Skin Infections.

Antibiotics (Basel, Switzerland)·2025

Same author

Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer.

Journal for immunotherapy of cancer·2025

Same author

Modulation of immunoglobulin G oligomerization by variable domain glycans: A mechanism to regulate complement activation.

PNAS nexus·2025

Search research articles

Related Experiment Video

Updated: Jul 5, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Competition-based cellular peptide binding assay for HLA class I.

Jan H Kessler¹, Willemien E Benckhuijsen, Tuna Mutis

¹Leiden University Medical Center, Leiden, Netherlands.

Current Protocols in Immunology

|April 25, 2008

Summary

This study presents a straightforward competition assay to measure how well unlabeled peptides bind to common HLA class I molecules. The assay quantifies peptide-HLA binding affinity using flow cytometry, providing IC50 values for various HLA alleles.

More Related Videos

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

Related Experiment Videos

Last Updated: Jul 5, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

Area of Science:

Immunology
Molecular Biology
Biochemistry

Background:

Human Leukocyte Antigen (HLA) class I molecules present peptides to cytotoxic T lymphocytes, playing a crucial role in immune response.
Understanding peptide-HLA binding is essential for developing immunotherapies, vaccines, and diagnosing autoimmune diseases.
Existing methods for assessing peptide-HLA binding can be complex and require specialized equipment.

Purpose of the Study:

To describe a novel competition assay for determining the binding affinity of unlabeled peptides to prevalent HLA class I molecules.
To provide a user-friendly and accessible method for quantifying peptide-HLA interactions in a standard cellular laboratory setting.

Main Methods:

The assay utilizes cells expressing specific HLA class I molecules, fluorescently labeled reference peptides, and unlabeled test peptides.
Cells are acid-treated to remove natural peptides, then incubated with labeled reference peptide and varying concentrations of test peptide.
Fluorescence-activated cell sorting (FACS) analysis quantifies bound reference peptide, enabling calculation of IC50 values.

Main Results:

The assay successfully determines the binding capacity (IC50 values) of unlabeled test peptides to thirteen common HLA class I molecules.
The method is shown to be robust and reproducible, requiring only standard laboratory equipment and a flow cytometer.
Assay-specific parameters for several HLA alleles are provided, facilitating direct application.

Conclusions:

This competition assay offers a practical and accessible approach to study peptide-HLA class I binding.
The assay's ease of use and minimal equipment requirements make it suitable for broad application in immunological research and diagnostics.
The provided IC50 values and allele-specific parameters enhance the utility of this method for peptide-HLA interaction studies.